Tech Times on MSN
HER2-positive breast cancer trial reports 92% survival in chemo-free patients; proof pending
HER2-positive breast cancer chemotherapy can be safely omitted in about 30% of patients, five-year PHERGain trial data ...
Self-expanding valves, a history of stroke, renal dysfunction and nontransfemoral access were all linked to an increased risk ...
In HELIOS-B (A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy), vutrisiran reduced the risk of all-cause mortality (ACM) and recurrent cardiovascular ...
What’s New in Clinical Management? / BRAF V600E, cancer, classic HCL, Hairy Cell Leukemia, HCL, Hematology, OncoDaily, ...
A machine learning study of 411,863 women across eleven Sub-Saharan African countries achieved 90.2 percent accuracy in ...
A new review finds recurring gut microbiome signatures associated with Alzheimer's disease biomarkers, while most ...
Explore LungÕ 2026's focus on locally advanced lung cancer, including PACIFIC, LAURA, perioperative immunotherapy, ...
Background Diabetes mellitus (DM) is associated with an increased risk of cardiovascular disease, but its relationship with ...
Introduction As individuals approach the end of life, physical, mental and social functions decline. However, reliable methods to detect and characterise symptoms of the terminal phase in people with ...
Image source: The Motley Fool. Senior Vice President of Investor Relations and Corporate Affairs-Sandra Coombs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results